GlassScriptPhysician profile
Andrew Billon
NPI 1922086131
$127,821.70
in general payments reported to CMS, 2019-2025
27 companies · $62K in 2025
The $62K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $241 · 2021: $104 · 2022: $273 · 2023: $231 · 2024: $64K · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $103K · Consulting Fee: $23K · Food and Beverage: $517 · Entertainment: $25.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $103,300.00 |
| Consulting Fee | $23,110.00 |
| Food and Beverage | $516.62 |
| Entertainment | $25.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evologics LLC | $126,410.00 | 2024-2025 | |
| Ethicon US, LLC | $216.10 | 2019-2025 | Echelon; Endopath, Enseal, Enseal X1 |
| Intuitive Surgical, INC. | $137.13 | 2022-2024 | Da Vinci Surgical System |
| Cumberland Pharmaceuticals, INC. | $136.79 | 2019-2023 | Caldolor |
| W. L. Gore & Associates, INC. | $130.82 | 2019-2024 | Gore Synecor Biomaterial |
| Ferring Pharmaceuticals INC. | $117.61 | 2019-2022 | |
| Smith+Nephew, INC. | $91.22 | 2019-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.18 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $63.26 | 2019-2023 | Exparel, Zilretta, Iovera |
| Janssen Pharmaceuticals, INC | $39.92 | 2022-2023 | Xarelto |
| Hologic Sales and Service, LLC | $38.21 | 2025 | Sentimag, Magtrace |
| Baudax Bio INC. | $37.49 | 2020 | |
| Braintree Laboratories, INC. | $35.97 | 2020-2022 | |
| Acelrx Pharmaceuticals, INC. | $31.77 | 2019-2020 | |
| Axonics, INC. | $30.16 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kub Technologies INC. | $25.72 | 2023 | Mozart |
| Allergan, INC. | $24.68 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $24.64 | 2024 | Voquezna |
| Abbott Laboratories | $24.13 | 2022 | |
| Inari Medical, INC. | $20.10 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Innocoll Pharmaceuticals Limited | $18.52 | 2022 | |
| Lilly USA, LLC | $15.40 | 2025 | Zepbound, Mounjaro |
| Kci USA, INC. | $15.38 | 2019 | |
| Vivus LLC | $14.99 | 2023 | Qsymia |
| Paratek Pharmaceuticals, INC. | $12.67 | 2020 | |
| Endogastric Solutions, INC | $10.25 | 2019 | |
| Lifenet Health | $9.59 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Billon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.